Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

By News Health
44 minutes Ago

(MedPage Today) — NEW ORLEANS — Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy.
In patients with relatively…

Source link : https://www.medpagetoday.com/meetingcoverage/isc/119779

Author :

Publish date : 2026-02-06 20:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

As ICE Uses Medicaid Data, Hospitals Are in a Bind Over Warning Immigrant Patients

FDA Updates Risks in Capecitabine, Fluorouracil Labels

FDA Calls for Testing Before Treatment With Widely Used Chemotherapies

Rural America Needs Immigrant Doctors More Than Ever

Intrusive thoughts? John has a room for that

Emails Undermine RFK Jr.'s Testimony on His Trip to Samoa Before a Measles Outbreak